Total Knee Arthroplasty. Loose body in knee
Conditions
Interventions
Intervention 1: Intervention group: Local injection of 500 mg of fibrinogen dissolved powder manufactured by CSL Behring USA in 10 ml of normal saline in the knee joint 2 minutes before opening tourni
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients candidate of Total Knee Arthroplasty (TKA) Age group 40-70 years American Society of Anesthesiologists (ASA) classification I , II
Exclusion criteria
Exclusion criteria: Patients with cardiovascular diseases Patients with anemia or bleeding disorders Consumption of Anticoagulant medications History of knee arthroscopy History of deep vein thrombosis High Body Mass Index
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post-operative bleeding. Timepoint: 0, 6 and 24 hours after surgery. Method of measurement: Blood volume in Hemovac. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemoglobin. Timepoint: 0, 6 and 24 hours after surgery. Method of measurement: Blood test.;Prothrombin time (PT). Timepoint: 0, 6 and 24 hours after surgery. Method of measurement: Blood test.;Partial thromboplastin time (PTT). Timepoint: 0, 6 and 24 hours after surgery. Method of measurement: Blood test.;Hematocrit (HCT). Timepoint: 0, 6 and 24 hours after surgery. Method of measurement: Blood test.;Plasma level of fibrinogen. Timepoint: 0, 6 and 24 hours after surgery. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHojatollah Khadem Ali
Ahvaz University of Medical Sciences
Outcome results
None listed